PNTG
$31.05-1.01 (-3.15%)
The Pennant Group, Inc.
Recent News
The Pennant Group Highlights Acquisition Momentum, Conservative Guidance at Oppenheimer Healthcare Chat
The Pennant Group (NASDAQ:PNTG) executives struck an optimistic tone about business momentum and growth initiatives during a fireside chat at Oppenheimer’s 36th Annual Healthcare Conference, while also emphasizing a measured approach to integrating major acquisitions and navigating a shifting compet
Auna S.A. Sees Strong Gains From Peru: More Upside on the Horizon
AUNA's Peru operations shine with double-digit revenue and EBITDA growth, driven by high-complexity care and expanded health plan reach.
1 Momentum Stock to Research Further and 2 We Ignore
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
1 Growth Stock with Explosive Upside and 2 We Avoid
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
3 Reasons to Avoid PNTG and 1 Stock to Buy Instead
The Pennant Group has had an impressive run over the past six months as its shares have beaten the S&P 500 by 30%. The stock now trades at $34.03, marking a 33% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.